Education
About Us
Working with TipRanks
Follow Us
Aceso Life Science Group Limited (HK:0474)
:0474
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 195.00M | HK$ 11.00M | HK$ 312.00M | HK$ 315.00M | HK$ 346.00M |
| Gross Profit | HK$ 90.00M | HK$ -100.00M | HK$ 141.00M | HK$ 162.00M | HK$ 213.00M |
| Operating Income | HK$ -24.00M | HK$ -224.00M | HK$ -153.00M | HK$ 10.00M | HK$ 16.00M |
| EBITDA | HK$ -860.00M | HK$ -220.00M | HK$ -21.00M | HK$ -359.00M | HK$ -69.00M |
| Net Income | HK$ -895.00M | HK$ -462.00M | HK$ -264.00M | HK$ -370.00M | HK$ -376.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 207.00M | HK$ 466.00M | HK$ 602.00M | HK$ 717.00M | HK$ 786.00M |
| Total Assets | HK$ 3.24B | HK$ 4.79B | HK$ 6.30B | HK$ 6.26B | HK$ 6.17B |
| Total Debt | HK$ 2.30B | HK$ 2.74B | HK$ 2.34B | HK$ 3.01B | HK$ 2.76B |
| Net Debt | HK$ 2.17B | HK$ 2.37B | HK$ 2.16B | HK$ 2.81B | HK$ 2.56B |
| Total Liabilities | HK$ 2.50B | HK$ 2.97B | HK$ 3.73B | HK$ 3.44B | HK$ 3.15B |
| Stockholders' Equity | HK$ 12.00M | HK$ 921.00M | HK$ 1.55B | HK$ 2.00B | HK$ 2.38B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 15.00M | HK$ -48.00M | HK$ 175.00M | HK$ 259.00M | HK$ 164.00M |
| Operating Cash Flow | HK$ 17.00M | HK$ -37.00M | HK$ 222.00M | HK$ 316.00M | HK$ 179.00M |
| Investing Cash Flow | HK$ 337.00M | HK$ 472.00M | HK$ -120.00M | HK$ -441.00M | HK$ -10.00M |
| Financing Cash Flow | HK$ -587.00M | HK$ 117.00M | HK$ -98.00M | HK$ 126.00M | HK$ -375.00M |